Close Menu

NEW YORK – Laboratory Corporation of America on Thursday reported 6 percent year-over-year revenue growth for the fourth quarter, driven by growth in its diagnostics and Covance drug development businesses.

Total revenues for the quarter ended Dec. 31, 2019 were $2.95 billion, up from $2.79 billion in the same quarter last year and beating analysts' average estimate of $2.93 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.